-
1
-
-
84929620816
-
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011
-
25304271
-
Q.T.Ostrom, H.Gittleman, P.Liao, C.Rouse, Y.Chen, J.Dowling, Y.Wolinsky, C.Kruchko, J.Barnholtz-Sloan. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 2014; 16 Suppl 4:iv1-63; PMID:25304271; 10.1093/neuonc/nou223
-
(2014)
Neuro Oncol
, vol.16
, pp. v1-v63
-
-
Ostrom, Q.T.1
Gittleman, H.2
Liao, P.3
Rouse, C.4
Chen, Y.5
Dowling, J.6
Wolinsky, Y.7
Kruchko, C.8
Barnholtz-Sloan, J.9
-
2
-
-
70450213189
-
Glioblastoma-derived mechanisms of systemic immunosuppression
-
19944964
-
A.Waziri Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin N Am 2010; 21:31-42; PMID:19944964; 10.1016/j.nec.2009.08.005
-
(2010)
Neurosurg Clin N Am
, vol.21
, pp. 31-42
-
-
Waziri, A.1
-
3
-
-
84896951629
-
Novel approaches and mechanisms of immunotherapy for glioblastoma
-
24641957
-
M.Hegde, K.J.Bielamowicz, N.Ahmed. Novel approaches and mechanisms of immunotherapy for glioblastoma. Discov Med 2014; 17:145-54; PMID:24641957
-
(2014)
Discov Med
, vol.17
, pp. 145-154
-
-
Hegde, M.1
Bielamowicz, K.J.2
Ahmed, N.3
-
4
-
-
77954629353
-
Immunotherapy for glioblastoma: a long and winding road
-
20308309
-
M.Weller Immunotherapy for glioblastoma: a long and winding road. Neuro Oncol 2010; 12:319; PMID:20308309; 10.1093/neuonc/noq027
-
(2010)
Neuro Oncol
, vol.12
, pp. 319
-
-
Weller, M.1
-
5
-
-
65249138393
-
Myeloid-derived suppressor cells: linking inflammation and cancer
-
19342621
-
S.Ostrand-Rosenberg, P.Sinha. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182:4499-506; PMID:19342621; 10.4049/jimmunol.0802740
-
(2009)
J Immunol
, vol.182
, pp. 4499-4506
-
-
Ostrand-Rosenberg, S.1
Sinha, P.2
-
6
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
19197294
-
D.I.Gabrilovich, S.Nagaraj. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74; PMID:19197294; 10.1038/nri2506
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
7
-
-
79960003585
-
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
-
21636707
-
B.Raychaudhuri, P.Rayman, J.Ireland, J.Ko, B.Rini, E.C.Borden, J.Garcia, M.A.Vogelbaum, J.Finke. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol 2011; 13:591-9; PMID:21636707; 10.1093/neuonc/nor042
-
(2011)
Neuro Oncol
, vol.13
, pp. 591-599
-
-
Raychaudhuri, B.1
Rayman, P.2
Ireland, J.3
Ko, J.4
Rini, B.5
Borden, E.C.6
Garcia, J.7
Vogelbaum, M.A.8
Finke, J.9
-
8
-
-
84866941861
-
Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development
-
23017140
-
G.Kohanbash, H.Okada. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Invest 2012; 41:658-79; PMID:23017140; 10.3109/08820139.2012.689591
-
(2012)
Immunol Invest
, vol.41
, pp. 658-679
-
-
Kohanbash, G.1
Okada, H.2
-
9
-
-
28044445899
-
Role of immature myeloid cells in mechanisms of immune evasion in cancer
-
16047143
-
S.Kusmartsev, D.I.Gabrilovich. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 2006; 55:237-45; PMID:16047143; 10.1007/s00262-005-0048-z
-
(2006)
Cancer Immunol Immunother
, vol.55
, pp. 237-245
-
-
Kusmartsev, S.1
Gabrilovich, D.I.2
-
10
-
-
41149148269
-
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
-
18364002
-
P.C.Rodriguez, A.C.Ochoa. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 2008; 222:180-91; PMID:18364002; 10.1111/j.1600-065X.2008.00608.x
-
(2008)
Immunol Rev
, vol.222
, pp. 180-191
-
-
Rodriguez, P.C.1
Ochoa, A.C.2
-
11
-
-
34447118098
-
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
-
17603493
-
S.Nagaraj, K.Gupta, V.Pisarev, L.Kinarsky, S.Sherman, L.Kang, D.L.Herber, J.Schneck, D.I.Gabrilovich. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007; 13:828-35; PMID:17603493; 10.1038/nm1609
-
(2007)
Nat Med
, vol.13
, pp. 828-835
-
-
Nagaraj, S.1
Gupta, K.2
Pisarev, V.3
Kinarsky, L.4
Sherman, S.5
Kang, L.6
Herber, D.L.7
Schneck, J.8
Gabrilovich, D.I.9
-
12
-
-
84875462761
-
Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer
-
23440412
-
J.Yu, W.Du, F.Yan, Y.Wang, H.Li, S.Cao, W.Yu, C.Shen, J.Liu, X.Ren. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J Immunol 2013; 190:3783-97; PMID:23440412; 10.4049/jimmunol.1201449
-
(2013)
J Immunol
, vol.190
, pp. 3783-3797
-
-
Yu, J.1
Du, W.2
Yan, F.3
Wang, Y.4
Li, H.5
Cao, S.6
Yu, W.7
Shen, C.8
Liu, J.9
Ren, X.10
-
13
-
-
66949145484
-
Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells
-
19380816
-
C.A.Corzo, M.J.Cotter, P.Cheng, F.Cheng, S.Kusmartsev, E.Sotomayor, T.Padhya, T.V.McCaffrey, J.C.McCaffrey, D.I.Gabrilovich. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009; 182:5693-701; PMID:19380816; 10.4049/jimmunol.0900092
-
(2009)
J Immunol
, vol.182
, pp. 5693-5701
-
-
Corzo, C.A.1
Cotter, M.J.2
Cheng, P.3
Cheng, F.4
Kusmartsev, S.5
Sotomayor, E.6
Padhya, T.7
McCaffrey, T.V.8
McCaffrey, J.C.9
Gabrilovich, D.I.10
-
14
-
-
34548805636
-
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
-
17617589
-
P.Sinha, V.K.Clements, S.K.Bunt, S.M.Albelda, S.Ostrand-Rosenberg. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179:977-83; PMID:17617589; 10.4049/jimmunol.179.2.977
-
(2007)
J Immunol
, vol.179
, pp. 977-983
-
-
Sinha, P.1
Clements, V.K.2
Bunt, S.K.3
Albelda, S.M.4
Ostrand-Rosenberg, S.5
-
15
-
-
59849126377
-
Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1
-
19109155
-
H.Li, Y.Han, Q.Guo, M.Zhang, X.Cao. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 2009; 182:240-9; PMID:19109155; 10.4049/jimmunol.182.1.240
-
(2009)
J Immunol
, vol.182
, pp. 240-249
-
-
Li, H.1
Han, Y.2
Guo, Q.3
Zhang, M.4
Cao, X.5
-
16
-
-
78649610261
-
IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function
-
21110318
-
M.Elkabets, V.S.Ribeiro, C.A.Dinarello, S.Ostrand-Rosenberg, J.P.Di Santo, R.N.Apte, C.A.Vosshenrich. IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol 2010; 40:3347-57; PMID:21110318; 10.1002/eji.201041037
-
(2010)
Eur J Immunol
, vol.40
, pp. 3347-3357
-
-
Elkabets, M.1
Ribeiro, V.S.2
Dinarello, C.A.3
Ostrand-Rosenberg, S.4
Di Santo, J.P.5
Apte, R.N.6
Vosshenrich, C.A.7
-
17
-
-
43249130187
-
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
-
18272812
-
K.Movahedi, M.Guilliams, J.Van den Bossche, R.Van den Bergh, C.Gysemans, A.Beschin, P.De Baetselier, J.A.Van Ginderachter. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008; 111:4233-44; PMID:18272812; 10.1182/blood-2007-07-099226
-
(2008)
Blood
, vol.111
, pp. 4233-4244
-
-
Movahedi, K.1
Guilliams, M.2
Van den Bossche, J.3
Van den Bergh, R.4
Gysemans, C.5
Beschin, A.6
De Baetselier, P.7
Van Ginderachter, J.A.8
-
18
-
-
54049134747
-
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
-
18832739
-
J.I.Youn, S.Nagaraj, M.Collazo, D.I.Gabrilovich. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181:5791-802; PMID:18832739; 10.4049/jimmunol.181.8.5791
-
(2008)
J Immunol
, vol.181
, pp. 5791-5802
-
-
Youn, J.I.1
Nagaraj, S.2
Collazo, M.3
Gabrilovich, D.I.4
-
19
-
-
77954641353
-
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
-
20308313
-
J.C.Rodrigues, G.C.Gonzalez, L.Zhang, G.Ibrahim, J.J.Kelly, M.P.Gustafson, Y.Lin, A.B.Dietz, P.A.Forsyth, V.W.Yong et al. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol 2010; 12:351-65; PMID:20308313; 10.1093/neuonc/nop023
-
(2010)
Neuro Oncol
, vol.12
, pp. 351-365
-
-
Rodrigues, J.C.1
Gonzalez, G.C.2
Zhang, L.3
Ibrahim, G.4
Kelly, J.J.5
Gustafson, M.P.6
Lin, Y.7
Dietz, A.B.8
Forsyth, P.A.9
Yong, V.W.10
-
20
-
-
84936797498
-
Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model
-
25537019
-
M.Chae, T.E.Peterson, A.Balgeman, S.Chen, L.Zhang, D.N.Renner, A.J.Johnson, I.F.Parney. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model. Neuro Oncol 2014; 17:978-91; PMID:25537019; 10.1093/neuonc/nou343
-
(2014)
Neuro Oncol
, vol.17
, pp. 978-991
-
-
Chae, M.1
Peterson, T.E.2
Balgeman, A.3
Chen, S.4
Zhang, L.5
Renner, D.N.6
Johnson, A.J.7
Parney, I.F.8
-
21
-
-
84887149333
-
GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-alpha
-
24030977
-
G.Kohanbash, K.McKaveney, M.Sakaki, R.Ueda, A.H.Mintz, N.Amankulor, M.Fujita, J.R.Ohlfest, H.Okada. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-alpha. Cancer Res 2013; 73:6413-23; PMID:24030977; 10.1158/0008-5472.CAN-12-4124
-
(2013)
Cancer Res
, vol.73
, pp. 6413-6423
-
-
Kohanbash, G.1
McKaveney, K.2
Sakaki, M.3
Ueda, R.4
Mintz, A.H.5
Amankulor, N.6
Fujita, M.7
Ohlfest, J.R.8
Okada, H.9
-
22
-
-
0033561756
-
Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers
-
10202033
-
J.P.Zou, L.A.Morford, C.Chougnet, A.R.Dix, A.G.Brooks, N.Torres, J.D.Shuman, J.E.Coligan, W.H.Brooks, T.L.Roszman et al. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J Immunol 1999; 162:4882-92; PMID:10202033
-
(1999)
J Immunol
, vol.162
, pp. 4882-4892
-
-
Zou, J.P.1
Morford, L.A.2
Chougnet, C.3
Dix, A.R.4
Brooks, A.G.5
Torres, N.6
Shuman, J.D.7
Coligan, J.E.8
Brooks, W.H.9
Roszman, T.L.10
-
23
-
-
84879484111
-
Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages
-
23613317
-
O.Bloch, C.A.Crane, R.Kaur, M.Safaee, M.J.Rutkowski, A.T.Parsa. Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res 2013; 19:3165-75; PMID:23613317; 10.1158/1078-0432.CCR-12-3314
-
(2013)
Clin Cancer Res
, vol.19
, pp. 3165-3175
-
-
Bloch, O.1
Crane, C.A.2
Kaur, R.3
Safaee, M.4
Rutkowski, M.J.5
Parsa, A.T.6
-
24
-
-
78349293679
-
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
-
20179016
-
M.P.Gustafson, Y.Lin, K.C.New, P.A.Bulur, B.P.O'Neill, D.A.Gastineau, A.B.Dietz. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 2010; 12:631-44; PMID:20179016; 10.1093/neuonc/noq001
-
(2010)
Neuro Oncol
, vol.12
, pp. 631-644
-
-
Gustafson, M.P.1
Lin, Y.2
New, K.C.3
Bulur, P.A.4
O'Neill, B.P.5
Gastineau, D.A.6
Dietz, A.B.7
-
25
-
-
78049270536
-
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
-
20667896
-
A.Wu, J.Wei, L.Y.Kong, Y.Wang, W.Priebe, W.Qiao, R.Sawaya, A.B.Heimberger. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 2010; 12:1113-25; PMID:20667896; 10.1093/neuonc/noq082
-
(2010)
Neuro Oncol
, vol.12
, pp. 1113-1125
-
-
Wu, A.1
Wei, J.2
Kong, L.Y.3
Wang, Y.4
Priebe, W.5
Qiao, W.6
Sawaya, R.7
Heimberger, A.B.8
-
26
-
-
77449124815
-
N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death
-
19920154
-
L.A.Earl, S.Bi, L.G.Baum. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J Biol Chem 2010; 285:2232-44; PMID:19920154; 10.1074/jbc.M109.066191
-
(2010)
J Biol Chem
, vol.285
, pp. 2232-2244
-
-
Earl, L.A.1
Bi, S.2
Baum, L.G.3
-
27
-
-
0029589620
-
Apoptosis of T cells mediated by galectin-1
-
7501023
-
N.L.Perillo, K.E.Pace, J.J.Seilhamer, L.G.Baum. Apoptosis of T cells mediated by galectin-1. Nature 1995; 378:736-9; PMID:7501023; 10.1038/378736a0
-
(1995)
Nature
, vol.378
, pp. 736-739
-
-
Perillo, N.L.1
Pace, K.E.2
Seilhamer, J.J.3
Baum, L.G.4
-
28
-
-
12144285871
-
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege
-
15050916
-
N.Rubinstein, M.Alvarez, N.W.Zwirner, M.A.Toscano, J.M.Ilarregui, A.Bravo, J.Mordoh, L.Fainboim, O.L.Podhajcer, G.A.Rabinovich. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004; 5:241-51; PMID:15050916; 10.1016/S1535-6108(04)00024-8
-
(2004)
Cancer Cell
, vol.5
, pp. 241-251
-
-
Rubinstein, N.1
Alvarez, M.2
Zwirner, N.W.3
Toscano, M.A.4
Ilarregui, J.M.5
Bravo, A.6
Mordoh, J.7
Fainboim, L.8
Podhajcer, O.L.9
Rabinovich, G.A.10
-
29
-
-
79959887879
-
Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis
-
21546572
-
A.Banh, J.Zhang, H.Cao, D.M.Bouley, S.Kwok, C.Kong, Q.T.Le. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 2011; 71:4423-31; PMID:21546572; 10.1158/0008-5472.CAN-10-4157
-
(2011)
Cancer Res
, vol.71
, pp. 4423-4431
-
-
Banh, A.1
Zhang, J.2
Cao, H.3
Bouley, D.M.4
Kwok, S.5
Kong, C.6
Le, Q.T.7
-
30
-
-
84889101128
-
Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype
-
23954858
-
R.Rostoker, H.Yaseen, S.Schif-Zuck, R.G.Lichtenstein, G.A.Rabinovich, A.Ariel. Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype. Prostaglandins Other Lipid Mediat 2013; 107:85-94; PMID:23954858; 10.1016/j.prostaglandins.2013.08.001
-
(2013)
Prostaglandins Other Lipid Mediat
, vol.107
, pp. 85-94
-
-
Rostoker, R.1
Yaseen, H.2
Schif-Zuck, S.3
Lichtenstein, R.G.4
Rabinovich, G.A.5
Ariel, A.6
-
31
-
-
84865351085
-
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration
-
22884314
-
S.C.Starossom, I.D.Mascanfroni, J.Imitola, L.Cao, K.Raddassi, S.F.Hernandez, R.Bassil, D.O.Croci, J.P.Cerliani, D.Delacour et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012; 37:249-63; PMID:22884314; 10.1016/j.immuni.2012.05.023
-
(2012)
Immunity
, vol.37
, pp. 249-263
-
-
Starossom, S.C.1
Mascanfroni, I.D.2
Imitola, J.3
Cao, L.4
Raddassi, K.5
Hernandez, S.F.6
Bassil, R.7
Croci, D.O.8
Cerliani, J.P.9
Delacour, D.10
-
32
-
-
84907569537
-
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity
-
25038230
-
G.J.Baker, P.Chockley, V.N.Yadav, R.Doherty, M.Ritt, S.Sivaramakrishnan, M.G.Castro, P.R.Lowenstein. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity. Cancer Res 2014; 74:5079-90; PMID:25038230; 10.1158/0008-5472.CAN-14-1203
-
(2014)
Cancer Res
, vol.74
, pp. 5079-5090
-
-
Baker, G.J.1
Chockley, P.2
Yadav, V.N.3
Doherty, R.4
Ritt, M.5
Sivaramakrishnan, S.6
Castro, M.G.7
Lowenstein, P.R.8
-
33
-
-
84907227971
-
Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients
-
25136121
-
C.A.Crane, K.Austgen, K.Haberthur, C.Hofmann, K.W.Moyes, L.Avanesyan, L.Fong, M.J.Campbell, S.Cooper, S.A.Oakes et al. Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. Proc Natl Acad Sci U S A 2014; 111:12823-8; PMID:25136121; 10.1073/pnas.1413933111
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 12823-12828
-
-
Crane, C.A.1
Austgen, K.2
Haberthur, K.3
Hofmann, C.4
Moyes, K.W.5
Avanesyan, L.6
Fong, L.7
Campbell, M.J.8
Cooper, S.9
Oakes, S.A.10
-
34
-
-
80355146868
-
Monocyte recruitment during infection and inflammation
-
21984070
-
C.Shi, E.G.Pamer. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11:762-74; PMID:21984070; 10.1038/nri3070
-
(2011)
Nat Rev Immunol
, vol.11
, pp. 762-774
-
-
Shi, C.1
Pamer, E.G.2
-
35
-
-
84907556027
-
Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy
-
25117977
-
G.J.Baker, V.N.Yadav, S.Motsch, C.Koschmann, A.A.Calinescu, Y.Mineharu, S.I.Camelo-Piragua, D.Orringer, S.Bannykh, W.S.Nichols et al. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia 2014; 16:543-61; PMID:25117977; 10.1016/j.neo.2014.06.003
-
(2014)
Neoplasia
, vol.16
, pp. 543-561
-
-
Baker, G.J.1
Yadav, V.N.2
Motsch, S.3
Koschmann, C.4
Calinescu, A.A.5
Mineharu, Y.6
Camelo-Piragua, S.I.7
Orringer, D.8
Bannykh, S.9
Nichols, W.S.10
-
36
-
-
84949473875
-
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
-
26650233
-
G.J.Baker, M.G.Castro, P.R.Lowenstein. Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells. J Vis Exp. 2015 Nov 28; (105); PMID:26650233; 10.3791/53676
-
J Vis Exp. 2015 Nov 28; (105)
-
-
Baker, G.J.1
Castro, M.G.2
Lowenstein, P.R.3
-
37
-
-
84860383557
-
Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis
-
22393124
-
B.N.Jaeger, J.Donadieu, C.Cognet, C.Bernat, D.Ordonez-Rueda, V.Barlogis, N.Mahlaoui, A.Fenis, E.Narni-Mancinelli, B.Beaupain et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med 2012; 209:565-80; PMID:22393124; 10.1084/jem.20111908
-
(2012)
J Exp Med
, vol.209
, pp. 565-580
-
-
Jaeger, B.N.1
Donadieu, J.2
Cognet, C.3
Bernat, C.4
Ordonez-Rueda, D.5
Barlogis, V.6
Mahlaoui, N.7
Fenis, A.8
Narni-Mancinelli, E.9
Beaupain, B.10
-
38
-
-
58149201572
-
A novel role for neutrophils as critical activators of NK cells
-
18981133
-
R.Sporri, N.Joller, H.Hilbi, A.Oxenius. A novel role for neutrophils as critical activators of NK cells. J Immunol 2008; 181:7121-30; PMID:18981133; 10.4049/jimmunol.181.10.7121
-
(2008)
J Immunol
, vol.181
, pp. 7121-7130
-
-
Sporri, R.1
Joller, N.2
Hilbi, H.3
Oxenius, A.4
-
39
-
-
58949086448
-
Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells
-
18753637
-
N.Nausch, I.E.Galani, E.Schlecker, A.Cerwenka. Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells. Blood 2008; 112:4080-9; PMID:18753637; 10.1182/blood-2008-03-143776
-
(2008)
Blood
, vol.112
, pp. 4080-4089
-
-
Nausch, N.1
Galani, I.E.2
Schlecker, E.3
Cerwenka, A.4
-
40
-
-
84866489404
-
Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion
-
22940097
-
S.M.Soudja, A.L.Ruiz, J.C.Marie, G.Lauvau. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 2012; 37:549-62; PMID:22940097; 10.1016/j.immuni.2012.05.029
-
(2012)
Immunity
, vol.37
, pp. 549-562
-
-
Soudja, S.M.1
Ruiz, A.L.2
Marie, J.C.3
Lauvau, G.4
-
41
-
-
8444253252
-
CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation
-
15528382
-
N.Dalbeth, R.Gundle, R.J.Davies, Y.C.Lee, A.J.McMichael, M.F.Callan. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004; 173:6418-26; PMID:15528382; 10.4049/jimmunol.173.10.6418
-
(2004)
J Immunol
, vol.173
, pp. 6418-6426
-
-
Dalbeth, N.1
Gundle, R.2
Davies, R.J.3
Lee, Y.C.4
McMichael, A.J.5
Callan, M.F.6
-
42
-
-
64249092437
-
Interactions between human NK cells and macrophages in response to Salmonella infection
-
19299734
-
N.Lapaque, T.Walzer, S.Meresse, E.Vivier, J.Trowsdale. Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 2009; 182:4339-48; PMID:19299734; 10.4049/jimmunol.0803329
-
(2009)
J Immunol
, vol.182
, pp. 4339-4348
-
-
Lapaque, N.1
Walzer, T.2
Meresse, S.3
Vivier, E.4
Trowsdale, J.5
-
43
-
-
33947608679
-
Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses
-
17218381
-
S.Nedvetzki, S.Sowinski, R.A.Eagle, J.Harris, F.Vely, D.Pende, J.Trowsdale, E.Vivier, S.Gordon, D.M.Davis. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 2007; 109:3776-85; PMID:17218381; 10.1182/blood-2006-10-052977
-
(2007)
Blood
, vol.109
, pp. 3776-3785
-
-
Nedvetzki, S.1
Sowinski, S.2
Eagle, R.A.3
Harris, J.4
Vely, F.5
Pende, D.6
Trowsdale, J.7
Vivier, E.8
Gordon, S.9
Davis, D.M.10
-
44
-
-
24944502182
-
LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction
-
16148169
-
O.Atochina, D.Harn. LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol 2005; 12:1041-9; PMID:16148169; 10.1128/CDLI.12.9.1041-1049.2005
-
(2005)
Clin Diagn Lab Immunol
, vol.12
, pp. 1041-1049
-
-
Atochina, O.1
Harn, D.2
-
45
-
-
79959338031
-
Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo
-
21541250
-
O.Chijioke, C.Munz. Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol 2011; 2011:251679; PMID:21541250; 10.1155/2011/251679
-
(2011)
J Biomed Biotechnol
, vol.2011
, pp. 251679
-
-
Chijioke, O.1
Munz, C.2
-
46
-
-
44349109733
-
Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction
-
18458347
-
M.Kijima, T.Yamaguchi, C.Ishifune, Y.Maekawa, A.Koyanagi, H.Yagita, S.Chiba, K.Kishihara, M.Shimada, K.Yasutomo. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci U S A 2008; 105:7010-5; PMID:18458347; 10.1073/pnas.0709919105
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 7010-7015
-
-
Kijima, M.1
Yamaguchi, T.2
Ishifune, C.3
Maekawa, Y.4
Koyanagi, A.5
Yagita, H.6
Chiba, S.7
Kishihara, K.8
Shimada, M.9
Yasutomo, K.10
-
47
-
-
20144380950
-
Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity
-
15778372
-
M.Schmitz, S.Zhao, Y.Deuse, K.Schakel, R.Wehner, H.Wohner, K.Hölig, F.Wienforth, A.Kiessling, M.Bornhäuser et al. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J Immunol 2005; 174:4127-34; PMID:15778372; 10.4049/jimmunol.174.7.4127
-
(2005)
J Immunol
, vol.174
, pp. 4127-4134
-
-
Schmitz, M.1
Zhao, S.2
Deuse, Y.3
Schakel, K.4
Wehner, R.5
Wohner, H.6
Hölig, K.7
Wienforth, F.8
Kiessling, A.9
Bornhäuser, M.10
-
48
-
-
0036786290
-
Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients
-
12239169
-
D.Valteau-Couanet, C.Leboulaire, K.Maincent, M.Tournier, O.Hartmann, J.Benard, F.Beaujean, C.Boccaccio, L.Zitvogel, E.Angevin. Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients. Blood 2002; 100:2554-61; PMID:12239169; 10.1182/blood.V100.7.2554
-
(2002)
Blood
, vol.100
, pp. 2554-2561
-
-
Valteau-Couanet, D.1
Leboulaire, C.2
Maincent, K.3
Tournier, M.4
Hartmann, O.5
Benard, J.6
Beaujean, F.7
Boccaccio, C.8
Zitvogel, L.9
Angevin, E.10
-
49
-
-
84856815290
-
Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon
-
22231304
-
A.Rivollier, J.He, A.Kole, V.Valatas, B.L.Kelsall. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 2012; 209:139-55; PMID:22231304; 10.1084/jem.20101387
-
(2012)
J Exp Med
, vol.209
, pp. 139-155
-
-
Rivollier, A.1
He, J.2
Kole, A.3
Valatas, V.4
Kelsall, B.L.5
-
50
-
-
51549091043
-
Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes
-
18714001
-
S.Watanabe, K.Deguchi, R.Zheng, H.Tamai, L.X.Wang, P.A.Cohen, S.Shu. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J Immunol 2008; 181:3291-300; PMID:18714001; 10.4049/jimmunol.181.5.3291
-
(2008)
J Immunol
, vol.181
, pp. 3291-3300
-
-
Watanabe, S.1
Deguchi, K.2
Zheng, R.3
Tamai, H.4
Wang, L.X.5
Cohen, P.A.6
Shu, S.7
-
51
-
-
84898597440
-
Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models
-
24192491
-
H.Shime, A.Kojima, A.Maruyama, Y.Saito, H.Oshiumi, M.Matsumoto, T.Seya. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models. J Innate Immun 2014; 6:293-305; PMID:24192491; 10.1159/000355126
-
(2014)
J Innate Immun
, vol.6
, pp. 293-305
-
-
Shime, H.1
Kojima, A.2
Maruyama, A.3
Saito, Y.4
Oshiumi, H.5
Matsumoto, M.6
Seya, T.7
-
52
-
-
84893736411
-
Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma
-
24434573
-
B.Thaci, A.U.Ahmed, I.V.Ulasov, D.A.Wainwright, P.Nigam, B.Auffinger, A.L.Tobias, Y.Han, L.Zhang, K.S.Moon et al. Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma. Cancer Gene Ther 2014; 21:38-44; PMID:24434573; 10.1038/cgt.2013.81
-
(2014)
Cancer Gene Ther
, vol.21
, pp. 38-44
-
-
Thaci, B.1
Ahmed, A.U.2
Ulasov, I.V.3
Wainwright, D.A.4
Nigam, P.5
Auffinger, B.6
Tobias, A.L.7
Han, Y.8
Zhang, L.9
Moon, K.S.10
-
53
-
-
84884556145
-
History of myeloid-derived suppressor cells
-
24060865
-
J.E.Talmadge, D.I.Gabrilovich. History of myeloid-derived suppressor cells. Nat Rev Cancer 2013; 13:739-52; PMID:24060865; 10.1038/nrc3581
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 739-752
-
-
Talmadge, J.E.1
Gabrilovich, D.I.2
-
54
-
-
43449117183
-
Evidence of galectin-1 involvement in glioma chemoresistance
-
18313712
-
M.Le Mercier, F.Lefranc, T.Mijatovic, O.Debeir, B.Haibe-Kains, G.Bontempi, C.Decaestecker, R.Kiss, V.Mathieu. Evidence of galectin-1 involvement in glioma chemoresistance. Toxicol Appl Pharmacol 2008; 229:172-83; PMID:18313712; 10.1016/j.taap.2008.01.009
-
(2008)
Toxicol Appl Pharmacol
, vol.229
, pp. 172-183
-
-
Le Mercier, M.1
Lefranc, F.2
Mijatovic, T.3
Debeir, O.4
Haibe-Kains, B.5
Bontempi, G.6
Decaestecker, C.7
Kiss, R.8
Mathieu, V.9
-
55
-
-
79960965896
-
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice
-
21680779
-
B.L.Mundy-Bosse, G.B.Lesinski, A.C.Jaime-Ramirez, K.Benninger, M.Khan, P.Kuppusamy, K.Guenterberg, S.V.Kondadasula, A.R.Chaudhury, K.M.La Perle et al. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res 2011; 71:5101-10; PMID:21680779; 10.1158/0008-5472.CAN-10-2670
-
(2011)
Cancer Res
, vol.71
, pp. 5101-5110
-
-
Mundy-Bosse, B.L.1
Lesinski, G.B.2
Jaime-Ramirez, A.C.3
Benninger, K.4
Khan, M.5
Kuppusamy, P.6
Guenterberg, K.7
Kondadasula, S.V.8
Chaudhury, A.R.9
La Perle, K.M.10
|